 |
BioWorld-International-2007-04-04
Gene Therapy Gains Boost With $690M Collaboration
Gene Therapy Gains Boost With $690M Collaboration
LONDON - Big pharma has publicly embraced gene therapy for the first time, with the signing of a $690 million deal between Sanofi-Aventis SA and Oxford BioMedica plc for TroVax. (BioWorld International)